No assessment of the merits of running a public awareness campaign to remove all COVID-19 signs has been made.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/1506", "label" : {"_value" : "Biography information for Andrew Gwynne"} } , "answeringMemberConstituency" : {"_value" : "Gorton and Denton"} , "answeringMemberPrinted" : {"_value" : "Andrew Gwynne"} , "dateOfAnswer" : {"_value" : "2024-10-31", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2024-10-31T14:49:55.293Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health and Social Care"} , "answeringDeptSortName" : {"_value" : "Health and Social Care"} , "date" : {"_value" : "2024-10-29", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Coronavirus: Health Education"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for Health and Social Care, what assessment she has made of the potential merits of running a public awareness campaign to remove all COVID signs.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : "http://data.parliament.uk/members/5158", "tablingMemberConstituency" : {"_value" : "Great Yarmouth"} , "tablingMemberPrinted" : [{"_value" : "Rupert Lowe"} ], "uin" : "11724"} , {"_about" : "http://data.parliament.uk/resources/1737301", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/1737301/answer", "answerText" : {"_value" : "
The study abstract has been reviewed by the Medicines and Healthcare products Regulatory Agency (MHRA), as part of its continuous post approval safety monitoring procedures for the Pfizer-BioNTech COVID-19 Vaccine (Comirnaty). The abstract is available at the following link:<\/p>
https://catalogues.ema.europa.eu/system/files/2024-06/C4591021%20Interim%205%20Study%20Report%20Abstract%20_0.pdf<\/a><\/p> The MHRA does not consider that any regulatory action is warranted at this time and will review the final study report, when it\u2019s made available by Pfizer, as part of safety monitoring procedures.<\/p> The MHRA does not publish study reports for company studies, and further publications of results are the responsibility of Pfizer-BioNTech. The MHRA continues to closely monitor the safety of all COVID-19 vaccines and will take any regulatory action necessary should any new safety concerns be identified.<\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/1506", "label" : {"_value" : "Biography information for Andrew Gwynne"}
}
, "answeringMemberConstituency" : {"_value" : "Gorton and Denton"}
, "answeringMemberPrinted" : {"_value" : "Andrew Gwynne"}
, "dateOfAnswer" : {"_value" : "2024-10-31", "_datatype" : "dateTime"}
, "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2024-10-31T12:59:08.553Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "17"}
, "answeringDeptShortName" : {"_value" : "Health and Social Care"}
, "answeringDeptSortName" : {"_value" : "Health and Social Care"}
, "date" : {"_value" : "2024-10-28", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Coronavirus: Vaccination"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 14 October 2024 to Question 6194 on Coronavirus: Vaccination, whether the Medicines and Healthcare products Regulatory Agency has made an assessment of the potential implications for future medical decisions of the Pfizer study abstract entitled, Post Conditional Approval Active Surveillance Study Among Individuals in Europe Receiving the Pfizer-BioNTech Coronavirus Disease 2019 (COVID-19) Vaccine, dated 12 March 2024; and when he plans to publish the full study.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/4084", "label" : {"_value" : "Biography information for Esther McVey"}
}
, "tablingMemberConstituency" : {"_value" : "Tatton"}
, "tablingMemberPrinted" : [{"_value" : "Esther McVey"}
], "uin" : "11248"}
, {"_about" : "http://data.parliament.uk/resources/1737432", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/1737432/answer", "answerText" : {"_value" : " No specific assessment has been made. The Government sympathises with the difficulties women experiencing menopausal symptoms face, and we are committed to prioritising women\u2019s health as we reform the National Health Service.<\/p> The NHS website provides information and advice for women on menopause symptoms, healthcare support, including treatment options, and advice on lifestyles changes, including diet and exercise. NHS England has also developed a self-care fact sheet. This fact sheet is available at the following link:<\/p> https://www.selfcareforum.org/menopause/<\/a><\/p> Women should not have to suffer in silence and anyone needing advice on managing symptoms should seek advice from their general practitioner or other healthcare professional. In addition, the Department has invested £25 million over 2023/24 and 2024/25 to support the establishment of at least one pilot women\u2019s health hub in every integrated care system. Menopause care is a core service for the pilot women\u2019s health hubs.<\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/4444", "label" : {"_value" : "Biography information for Karin Smyth"}
}
, "answeringMemberConstituency" : {"_value" : "Bristol South"}
, "answeringMemberPrinted" : {"_value" : "Karin Smyth"}
, "dateOfAnswer" : {"_value" : "2024-10-31", "_datatype" : "dateTime"}
, "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2024-10-31T17:38:00.573Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "17"}
, "answeringDeptShortName" : {"_value" : "Health and Social Care"}
, "answeringDeptSortName" : {"_value" : "Health and Social Care"}
, "date" : {"_value" : "2024-10-28", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Menopause: Health Services"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Health and Social Care, if he will make an assessment of the potential merits of a permanent national menopause network supported by specialist nurses to (a) support and (b) offer advice on (i) diet, (ii) exercise, (iii) the workplace and (iv) other issues to people going through the menopause.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/4658", "label" : {"_value" : "Biography information for Alex Sobel"}
}
, "tablingMemberConstituency" : {"_value" : "Leeds Central and Headingley"}
, "tablingMemberPrinted" : [{"_value" : "Alex Sobel"}
], "uin" : "11311"}
, {"_about" : "http://data.parliament.uk/resources/1737465", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/1737465/answer", "answerText" : {"_value" : " As of the end of June 2024, community diagnostics centres (CDCs) had delivered 9,292,578 tests, checks and scans since the 2021 Spending Review at the end of October. Over this period, the diagnostic waiting list has increased from 1,428,415 as at the end of October 2021 where 356,784 (25.0%) people were waiting over six weeks, to 1,639,813 at the end of June 2024 where 375,416 (23.9%) people were waiting over 6-weeks for a diagnostic test. 2024/25 NHS Operational Planning Guidance set an objective for just 5% to be waiting six weeks. Due to seasonal effects, some care should be exercised when comparing six week wait percentages figures in different months of the year.<\/p> CDC activity data is published monthly and cannot be provided up to a specific date within that month. Published CDC activity data details activity from July 2021 to August 2024. This is available at the following link:<\/p>
Month<\/p><\/td> | CDC activity delivered since Oct-21 Spending Review<\/p><\/td> | CDC activity delivered in each month<\/p><\/td><\/tr> | ||||||||||||||||||||||||
Jan-24<\/p><\/td> | 6,841,026<\/p><\/td> | 393,742<\/p><\/td><\/tr> | ||||||||||||||||||||||||
Feb-24<\/p><\/td> | 7,279,148<\/p><\/td> | 438,122<\/p><\/td><\/tr> | ||||||||||||||||||||||||
Mar-24<\/p><\/td> | 7,826,454<\/p><\/td> | 547,306<\/p><\/td><\/tr> | ||||||||||||||||||||||||
Apr-24<\/p><\/td> | 8,263,510<\/p><\/td> | 437,056<\/p><\/td><\/tr> | ||||||||||||||||||||||||
May-24<\/p><\/td> | 8,718,759<\/p><\/td> | 455,249<\/p><\/td><\/tr> | ||||||||||||||||||||||||
Jun-24<\/p><\/td> | 9,292,578<\/p><\/td> | 573,819<\/p><\/td><\/tr> | ||||||||||||||||||||||||
Jul-24<\/p><\/td> | 9,771,674<\/p><\/td> | 479,096<\/p><\/td><\/tr><\/tbody><\/table> Source: NHS England<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4444", "label" : {"_value" : "Biography information for Karin Smyth"} } , "answeringMemberConstituency" : {"_value" : "Bristol South"} , "answeringMemberPrinted" : {"_value" : "Karin Smyth"} , "dateOfAnswer" : {"_value" : "2024-10-31", "_datatype" : "dateTime"} , "groupedQuestionUIN" : {"_value" : "11318"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2024-10-31T17:52:16.1Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health and Social Care"} , "answeringDeptSortName" : {"_value" : "Health and Social Care"} , "date" : {"_value" : "2024-10-28", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Community Diagnostic Centres"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for Health and Social Care, how many (a) checks, (b) tests and (c) scans were carried out at community diagnostic centres opened since the 2021 Spending Review, as of 4 July 2024.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4399", "label" : {"_value" : "Biography information for Victoria Atkins"} } , "tablingMemberConstituency" : {"_value" : "Louth and Horncastle"} , "tablingMemberPrinted" : [{"_value" : "Victoria Atkins"} ], "uin" : "11317"} , {"_about" : "http://data.parliament.uk/resources/1737466", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/1737466/answer", "answerText" : {"_value" : " As of the end of June 2024, community diagnostics centres (CDCs) had delivered 9,292,578 tests, checks and scans since the 2021 Spending Review at the end of October. Over this period, the diagnostic waiting list has increased from 1,428,415 as at the end of October 2021 where 356,784 (25.0%) people were waiting over six weeks, to 1,639,813 at the end of June 2024 where 375,416 (23.9%) people were waiting over 6-weeks for a diagnostic test. 2024/25 NHS Operational Planning Guidance set an objective for just 5% to be waiting six weeks. Due to seasonal effects, some care should be exercised when comparing six week wait percentages figures in different months of the year.<\/p> CDC activity data is published monthly and cannot be provided up to a specific date within that month. Published CDC activity data details activity from July 2021 to August 2024. This is available at the following link:<\/p>
|